Bluebird bio Inc (BLUE) Financials

$4.97

$0.00 (0.00%)

As on 02-Jun-2025 09:30EDT

Market cap

$49 Mln

Revenue (TTM)

$104 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	103.95	83.81	29.50	3.60	3.66	250.73
Cost of Revenue	75.75	89.38	33.53	10.08	38.86	5.40
Gross Profit	28.19	-5.57	-4.03	-6.48	-35.20	245.34
Operating Expenses	238.66	262.13	273.76	275.67	529.92	874.85
Operating Profit (EBIT)	-216.38	-270.46	-244.26	-287.09	-590.91	-629.51
Other Income	--	--	--	--	27.65	-6.50
Profit before Tax	-199.81	-240.65	-212.04	-266.46	-562.38	-618.01
Provision for Tax	0.09	0.07	--	0.12	0.26	0.69
Profit after Tax (Net Income)	-199.98	-240.72	-211.91	-266.58	-562.64	-618.70
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-266.58	-819.38	-618.70

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-57.87	-31.53	194.54	196.34	374.28	1,355.06
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	38.75	170.30	224.51	230.32	66.53	222.61
Current Liabilities	315.08	321.46	200.11	128.24	152.99	203.59
Total Liabilities	611.04	460.23	619.16	554.90	593.80	1,781.25

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	121.43	305.56	337.48	355.41	257.28	565.72
Current Assets	174.52	154.67	281.69	199.49	336.52	1,215.54
Total Assets	611.04	460.23	--	554.90	593.80	1,781.25
Total Debt*	115.46	358.24	--	281.39	89.58	193.02
Net Current Assets	-140.55	-166.79	81.57	71.25	183.53	1,011.95

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-260.02	-235.05	-352.95	-635.64	-470.35
Cash Flow from Investing Activities	--	--	--	250.45	562.56	-84.35
Cash from Financing Activities	--	87.47	196.25	54.25	-93.95	546.72
Net Cash Inflow / Outflow	--	--	--	--	-167.04	-7.98

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-5.65	-3.75	-21.99	-3.13	-7.76	-9.32
Cash EPS ($)	--	-2.80	-19.03	-3.07	-7.49	-9.03
Adjusted Book Value ($)	--	--	20.18	2.30	5.16	20.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.06	-24.39	-4.14	-8.77	-7.08
Free Cash Flow per Share ($)	--	-4.10	-25.33	-4.30	-9.08	-7.52

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-92.36	-63.04	-56.62	-55.93	-40.92
ROE (%)	--	-295.35	-108.43	-93.43	-65.07	-46.87
ROA (%)	-26.04	-44.60	-36.10	-46.41	-47.38	-35.27
EBIT Margin (%)	-148.07	-260.20	--	-6,131.78	-15,357.18	-223.05
Net Margin (%)	-192.39	-287.23	-718.42	-7,411.12	-1,796.76	-253.32
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	127.51	1.84	7.20	-0.02	-0.99	4.61
EBIT Growth (%)	-0.98	--	--	60.78	-0.56	29.22
Net Profit Growth (%)	33.99	-13.59	20.51	52.62	9.06	21.65
EPS Growth (%)	68.14	0.83	-6.03	0.60	0.17	0.35
Book Value Growth (%)	-143.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-2.22	-0.06	-2.21	-1.29	-4.64
Price / Book Value	0.73	-16.96	0.07	3.00	1.94	2.12
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.50	-5.30	--	-3.20	-0.92	-3.46
Close Price ($)	4.88	8.34	27.60	138.40	199.80	560.21
High Price ($)	28.60	38.40	170.40	214.80	694.99	1,286.41
Low Price ($)	3.56	5.80	25.20	57.30	162.40	504.28
Market Cap ($ Cr)	48.67	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	-11.36	--	1.43	0.24	0.14
Short term debt to equity ratio	-1.33	-5.99	--	0.45	0.12	0.01
Current Ratio	0.55	0.48	1.41	1.56	2.20	5.97
Quick Ratio	0.29	0.28	1.29	1.57	2.91	6.71
Interest Coverage	-7.81	-9.66	--	-34.89	-2.16	-14.98

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	1.14	3.69	73.40	299.89	311.00	0.95
Asset Turnover	0.14	0.16	0.05	0.01	0.00	0.14
Receivable days	--	53.92	200.83	1,125.91	686.27	11.07
Inventory Days	--	179.67	117.14	-1,992.02	-1,213.56	-9,951.54
Payable days	--	107.91	181.74	738.51	186.56	1,922.57
Cash Conversion Cycle	--	125.68	136.23	-1,604.62	-713.85	-11,863.04

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.